Eli Lilly Stock Price

0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 0
Bid Price
Ask Price
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Eli Lilly and Co LLY NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 302.50 20:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 220.20 - 335.33
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 302.50 USD


Draw Mode:

Eli Lilly and Co Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 287.43B 950.17M 789.65M $ 28.32B $ 5.95B 6.13 44.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 3.40 1.30% 08/12/22 -1.70M 0.50%

more financials information »

Eli Lilly News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LLY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week326.59328.98296.53309.283,856,438-24.09-7.38%
1 Month330.00335.33296.53320.652,630,963-27.50-8.33%
3 Months298.61335.33283.11312.582,904,9313.891.3%
6 Months241.26335.33231.87294.362,903,63061.2425.38%
1 Year265.03335.33220.20272.642,885,68637.4714.14%
3 Years113.24335.33101.36190.223,443,217189.26167.13%
5 Years82.13335.3373.69148.744,184,741220.37268.32%

Eli Lilly Description

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Your Recent History
Eli Lilly
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now